glp-1 agonists drugs New Guidelines for Type 2 Diabetes in 2025 GLP-1 Receptor Agonists and Research
Description
GLP-1 gastroparesis emerges as a serious yet often overlooked complication for patients using these popular medications
[10] SURMOUNT-1 : Tirzepatide for the treatment of obesity produced ~2022% weight loss over 72 weeks, among the largest effects seen in pharmacologic obesity treatment
Obes Rev 25(11):e13811 Astrup A et al (2012) Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
In retail, global dietary supplement retailer GNC was the first to launch an in-store GLP-1 support program to combat medication side effects
SC, subcutaneous
Diabetes, Obesity & Metabolism, 23 ,
